Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals

Trompeter, Jessica M.; Havrda, Dawn E.

doi:10.1345/aph.1l420

Cited by 16 publications

(20 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All studies evaluated programs or policies that implemented ROPC for medications to treat patients with hypertension, hyperlipidemia, or both. Moreover, 7 of the 18 included studies used a VBID plan ( 24 , 25 , 27 , 28 , 33 , 34 , 37 ) and 3 studies used pharmaceutical medication assistance programs (PMAP) programs to procure medications for indigent patients ( 29 , 35 , 36 ). Although most studies also implemented medication counseling or patient education, they did not report ROPC for these services.…”

Section: Resultsmentioning

confidence: 99%

Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review

Njie¹,

Finnie

Acharya

et al. 2015

Prev. Chronic Dis.

View full text Add to dashboard Cite

IntroductionHypertension and hyperlipidemia are major cardiovascular disease risk factors. To modify them, patients often need to adopt healthier lifestyles and adhere to prescribed medications. However, patients’ adherence to recommended treatments has been suboptimal. Reducing out-of-pocket costs (ROPC) to patients may improve medication adherence and consequently improve health outcomes. This Community Guide systematic review examined the effectiveness of ROPC for medications prescribed for patients with hypertension and hyperlipidemia.MethodsWe assessed effectiveness and economics of ROPC for medications to treat hypertension, hyperlipidemia, or both. Per Community Guide review methods, reviewers identified, evaluated, and summarized available evidence published from January 1980 through July 2015.ResultsEighteen studies were included in the analysis. ROPC interventions resulted in increased medication adherence for patients taking blood pressure and cholesterol medications by a median of 3.0 percentage points; proportion achieving 80% adherence to medication increased by 5.1 percentage points. Blood pressure and cholesterol outcomes also improved. Nine studies were included in the economic review, with a median intervention cost of $172 per person per year and a median change in health care cost of −$127 per person per year.ConclusionROPC for medications to treat hypertension and hyperlipidemia is effective in increasing medication adherence, and, thus, improving blood pressure and cholesterol outcomes. Most ROPC interventions are implemented in combination with evidence-based health care interventions such as team-based care with medication counseling. An overall conclusion about the economics of the intervention could not be reached with the small body of inconsistent cost-benefit evidence.

show abstract

Section: Resultsmentioning

confidence: 99%

Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review

Njie¹,

Finnie

Acharya

et al. 2015

Prev. Chronic Dis.

View full text Add to dashboard Cite

show abstract

“…The clinical benefits of providing free medications to those in need are evident 24 . A recent finding showed a decrease in hospitalizations (n = 36) when cardiovascular drugs were obtained through PAPs 25 .…”

Section: Discussionmentioning

confidence: 99%

Monetary Value of a Prescription Assistance Program Service in a Rural Family Medicine Clinic

Whitley

2010

The Journal of Rural Health

View full text Add to dashboard Cite

PAPs offer an avenue to obtain medications when cost may lead to non-adherence. PAP services helped rurally isolated Alabamians receive needed therapies they otherwise likely would not have purchased. Similar programs offering assistance services for merely cardiovascular products would provide a substantial public health impact. Providers interested in initiating similar services should identify a program coordinator, designate a private location for patient interviews, and develop systems to ensure patients receive their PAP medications.

show abstract

“…Overall, financial support programmes have the potential to improve patient access, however the complexity of enrollment may dampen the impact of such efforts (Felder et al, 2011;Howard, 2014;Johnson, 2006;Trompeter and Havrda 2009).…”

Section: Taxonomy Of Health Care Programmesmentioning

confidence: 99%

“…• May lead to improvements in patient health outcomes (Trompeter and Havrda, 2009) • Transparency over eligibility criteria questionable (Choudhry et al, 2009) • Unclear whether programmes respond adequately to underinsured (Shelley, 2013) • Programmes require patient enrollment, but patients may not be aware programme exists or have the capacity to apply (Howard, 2014) • Need good management capabilities to implement programmes (Johnson, 2009) Patient education/ integrated care programmes…”

Section: Addressing Uncertaintymentioning

confidence: 99%

Towards High Quality Health Care and Sustainable Financing – the Role of Health Care Programmes

et al. 2016

View full text Add to dashboard Cite

This article develops a taxonomy of health care programmes, and assesses whether or not these programmes represent a viable option for addressing key health policy objectives, including efficiency, equity and sustainable financing. A broad literature review was undertaken to identify the various types of health care programmes to develop a taxonomy. Then, a targeted literature review of each type of health care programme was undertaken to collect evidence on the ability of programmes to address health policy objectives. Many health care programmes were identified and grouped into six categories: financial support, patient education, integrated care, special population, national/regional plans, and disease management. Design and implementation of these programmes varied widely within and across categories. Evidence surrounding impact of health care programmes was largely mixed, with evidence of both successful and unsuccessful initiatives. The evidence suggests that when properly implemented, health care programmes can help generate cost savings, improve patient adherence to treatment, address inequities in access to health care, and improve patient health outcomes. However, the evidence relies on a highly heterogeneous sample of studies, study populations and diseases studied; studies are often of variable quality. Further research on this subject would therefore be beneficial.

show abstract

Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals

Cited by 16 publications

References 25 publications

Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review

Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review

Monetary Value of a Prescription Assistance Program Service in a Rural Family Medicine Clinic

Towards High Quality Health Care and Sustainable Financing – the Role of Health Care Programmes

Contact Info

Product

Resources

About